IHM
BIIB icon

Iguana Healthcare Management’s Biogen BIIB Stock Holding History

Iguana Healthcare Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-10,000
Closed -$3.4M – 67
2014
Q4 		$3.4M Buy
+10,000
New +$3.24M 1.64% 23

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Iguana Healthcare Management's BIIB Position: Q1 2018 in Review

Iguana Healthcare Management reduced its Biogen (BIIB) stake by 20% in Q1 2018, selling an estimated $1.4M and leaving 17,500 shares worth $4.79M. The position accounts for 3.15% of the portfolio, ranked #6.

Iguana Healthcare Management first reported a position in BIIB in Q4 2013 and has held it in 17 quarters since. The position peaked at $20.3M in Q3 2016. 1,102 funds tracked by Wall St. Rank hold BIIB as of Q1 2018.

  • Iguana Healthcare Management held 17,500 shares of Biogen worth $4.79M as of Q1 2018.
  • Iguana Healthcare Management sold 4,500 Biogen shares in Q1 2018, an estimated $1.4M.
  • Biogen made up 3.15% of Iguana Healthcare Management's portfolio in Q1 2018, its #6 holding.
  • Iguana Healthcare Management first reported a position in Biogen in Q4 2013 and has held it in 17 quarters since.
  • Iguana Healthcare Management's Biogen position peaked at $20.3M in Q3 2016.
  • 1,102 funds tracked by Wall St. Rank held Biogen as of Q1 2018.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.